A Novel Approach for Overcoming Drug Resistance in Breast Cancer Chemotherapy by Targeting new Synthetic Curcumin Analogues Against Aldehyde Dehydrogenase 1 (ALDH1A1) and Glycogen Synthase Kinase-3 β (GSK-3β)
- 26 June 2015
- journal article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 176 (7) , 1996-2017
Abstract
Breast cancer stem cells are well known to resist the traditional methods like chemo and radio therapy. Aldehyde dehydrogenase 1 (ALDHIA1) and glycogen synthase kinase-3 β (GSK-3β) are the two selected proteins for study, due to their overexpression and upregulation in breast cancer cells. Curcumin, the yellow pigment of the spice turmeric, is widely reported as an antioxidant and acts as a synergist along with traditional drugs. Under hypoxic conditions, it gets converted to free radical which causes apoptosis. Three naturally occurring curcuminoids, i.e. curcumin, demethoxycurcumin, and bisdemethoxycurcumin along with five derivatives/analogues of curcumin, viz. 4,4′-di-O-(carboxy-methyl)-curcumin, 4-O-(2-hydroxyethyl)curcumin, 4,4′-di-O-allyl-curcumin, 4,4′-di-O-(acetyl)-curcumin, and 3,3′-bisdemethylcurcumin were synthesized and evaluated for their anti-breast cancer potential by docking simulation and assessment of their antioxidant character, studied via 2, 2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS·+) radical cation scavenging assay, 2,2-diphenyl-1-picrylhydrazyl (DPPH·) radical, and ferric reducing ability potential (FRAP) assay. A co-relation between structure and activity of curcuminoids/its analogues and derivatives has been worked out.Keywords
This publication has 39 references indexed in Scilit:
- Mechanisms of chemoresistance in cancer stem cellsClinical and Translational Medicine, 2013
- Aldehyde Dehydrogenase 1, a Potential Marker for Cancer Stem Cells in Human SarcomaPLOS ONE, 2012
- Structure-Based Design of Novel Boronic Acid-Based Inhibitors of AutotaxinJournal of Medicinal Chemistry, 2011
- More than Markers: Biological Significance of Cancer Stem Cell-Defining MoleculesMolecular Cancer Therapeutics, 2010
- RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivoBiochemical Pharmacology, 2010
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Research and Treatment, 2009
- Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapyJournal of Nanobiotechnology, 2007
- CURCUMIN: THE INDIAN SOLID GOLD2007
- The Protein Data BankNucleic Acids Research, 2000
- Structure-antioxidant activity relationships of flavonoids and phenolic acidsFree Radical Biology and Medicine, 1996